Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reilly

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 16, 2020
Genome-Wide Association for HbA1c in Malay Identified Deletion on SLC4A1 that Influences HbA1c Independent of GlycemiaJin-Fang Chai, Shih-Ling Kao, Chaolong Wang, et al.
The Journal of Experimental Medicine|February 14, 2023
The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progressionGiorgia Benegiamo, Giacomo V G von Alvensleben, Sandra Rodríguez-López, et al.
Cancer Research|March 4, 2010
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer modelClay L Efferson, Christopher T Winkelmann, Christopher Ware, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 2, 2000
Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulationA S Dutta, J J Gormley, M Coath, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2005
Adult mouse brain gene expression patterns bear an embryologic imprintMatthew A Zapala, Iiris Hovatta, Julie A Ellison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group studyEvanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Circulation|March 1, 1996
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosisW R Huckle, M D Drag, W R Acker, et al.
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Pediatric Blood & Cancer|March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effectiveMichael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Blood|November 17, 2021
DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adultsMargaret A Ferris, Amanda M Smith, Sharon E Heath, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
The Journal of Clinical Endocrinology and Metabolism|September 16, 2020
Genome-Wide Association for HbA1c in Malay Identified Deletion on SLC4A1 that Influences HbA1c Independent of GlycemiaJin-Fang Chai, Shih-Ling Kao, Chaolong Wang, et al.
The Journal of Experimental Medicine|February 14, 2023
The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progressionGiorgia Benegiamo, Giacomo V G von Alvensleben, Sandra Rodríguez-López, et al.
Cancer Research|March 4, 2010
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer modelClay L Efferson, Christopher T Winkelmann, Christopher Ware, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 2, 2000
Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulationA S Dutta, J J Gormley, M Coath, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2005
Adult mouse brain gene expression patterns bear an embryologic imprintMatthew A Zapala, Iiris Hovatta, Julie A Ellison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group studyEvanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Circulation|March 1, 1996
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosisW R Huckle, M D Drag, W R Acker, et al.
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Pediatric Blood & Cancer|March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effectiveMichael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Blood|November 17, 2021
DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adultsMargaret A Ferris, Amanda M Smith, Sharon E Heath, et al.
Pageof 32